Interferon-alpha 2a Reduces MRI Disease Activity in Relapsing-Remitting Multiple Sclerosis
Neurol 52:1049-1056, Myhr,K.M.,et al, 1999
Rapidly Progressive Dementia
Lancet 353:1150, Bornke,C.,et al, 1999
Magnetic Resonance Imaging-Based Volumetry Differentiates Idiopathic Parkinson's Syndrome from Multiple System Atrophy and Progressive Supranuclear Palsy
Ann Neurol 45:65-74, Schulz,J.B.,et al, 1999
Spastic Paraparesis after Anaesthesia
Lancet 353:554, Lee,P.,et al, 1999
Magnetization Transfer Imaging of Patients with Definite MS and Negative Conventional MRI
Neurol 52:845-848, Filippi,M.,et al, 1999
The Clinical Spectrum of Sarcoglycanopathies
Neurol 52:176-179, Angelini,C.,et al, 1999
Getting a Grip on the Myotonic Dystrophies
Neurol 52:12-13, Thornton,C.A.&Ashizawa,T., 1999
Multiple Sclerosis Associated with Uveitis in Two Large Clinic-Based Series
Neurol 52:179-181, Biousse,V.,et al, 1999
Hypoxic/Ischaemic Brain Damages, Especially Pallidal Lesions, in Heroin Addicts
Forensic Sci Int 102:51-59, Andersen,S.N. &Skullerud,K., 1999
Radiation-Associated Cerebral Blindness
Am J Ophthalmol 126:609-611, Pomeranz,H.D.,et al,, 1998
The Muscular Dystrophies
BMJ 317:991-995, Emery,A.E.H., 1998
Cardiac Involvement in Genetically Confirmed Facioscapulohumeral Muscular Dystrophy
Neurol 51:1454-1456, Laforet,P.,et al, 1998
Attitudes of Patients with Amyotrophic Lateral Sclerosis and Their Care Givers Toward Assisted Suicide
NEJM 339:967-973,987, Ganzini,L.,et al, 1998
Olfactory Dysfunction in Guamanian ALS,Parkinsonism,and Dementia
Neurol 51:1672-1677, Ahlskog,J.E.,et al, 1998
Early Structural Changes in Acute MS Lesions Assessed by Serial magnetization Transfer Studies
Neurol 51:1150-1155, Dousset,V.,et al, 1998
Amelioration of Flulike Symptoms at the Onset of Interferon B-1b Therapy in Multiple Sclerosis by Low-Dose Oral Steriods is Related to a Decrease in Interleukin-6 Induction
Ann Neurol 44:682-685, Martinez-Caceres,E.M.,et al, 1998
Neutralizing Antibodies to Interferon B-1a and Interferon B-1b in MS Patients are Cross-Reactive
Neurol 51:1698-1702, Khan,O.A. & Dhib-Jalbut,S., 1998
Tolterodine for Overactive Bladder
The Medical Letter 40:101-102, , 1998
A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998
Creutzfeldt-Jakob Disease and Related Transmissible Spongiform Encephalopathies
NEJM 339:1994-2004, Johnson,R.T. & Gibbs,Jr.,C.J., 1998
Granulomatous Compressive Thoracic Myelopathy as the Initial Manifestation of Wegener's Granulomatosis
Neurol 51:1769-1770, Kelly,P.J.,et al, 1998
Clinicopath Conf,Sarcoidosis,with Involvement of Spinal Cord,Brain,Mediastinal Lymph Nodes and ? Lung,Case 35-1998
NEJM 339:1534-1541, , 1998
Review of 23 Patients Affected by the Stiff Man Syndrome:Clinical Subdivision into Stiff Trunk (man) Syndrome,Stiff Limb Syndrome,and Progressive Encephalopmyelitis with Rigidity
JNNP 65:633-640, Barker,R.A.et al, 1998
Interferon B Therapy for Multiple Sclerosis
Lancet 352:1486-1487, Goodkin,D.E., 1998
Interferons in the Treatment of Multiple Sclerosis,Do They Prevent the Progression of the Disease?
Arch Neurol 55:1578-1580,1583, Rice,G.&Ebers,G, 1998
Interferons Should be Used to Treat Most Patients with MS
Arch Neurol 55:1581-1583, Herndon,R.M.&Jacobs,L, 1998
Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998
MR Appearance of an Intracranial Dural Arteriovenous Fistula Leading to Cervical Myelopathy
Neurol 51:1131-1135, Hahnel,S.,et al, 1998
The Phenotypic Spectrum of CADASIL:Clinical Findings in 102 Cases,
Ann Neurol 44:731-739,715, Dichgans,M.,et al, 1998
Effective of Chloroquine & Hydroxychloroquine in Treating Selected Pts with Sarcoidosis with Neurol Involve
Arch Neurol 55:1248-1254, Sharman,O.P.,et al, 1998
The Predictive Value of CSF Ologoclonal Banding for MS 5 Years After Optic Neuritis
Neurol 51:885-887, Cole,S.R.,et al, 1998
Variable Progression of HIV-Associated Dementia
Neurol 50:1814-1820, Bouwman,F.H.,et al, 1998
Incidence and Significance of Neutralizing Antibodies to Interferon Beta-1a in Multiple Sclerosis
Neurol 50:1266-1272, 12061998., Rudick,R.A.,et al, 1998
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
Hemianopsia in Dementia with Lewy Bodies
Arch Neurol 55:1132-1135, Bashir,K.,et al, 1998
Clinicopath Conf
Chronic Inflammatory Demyelinating Polyneuropathy, Case 13-1998, NEJM 338:1212-1219998., , 1998
Clinicopath Conf
Demyelinating Process Consistent with Multiple Sclerosis, Case 26-1998, NEJM 339:542-549998., , 1998
Magnetization Transfer Changes in Normal Appearing White Matter Precede Appear of Enhancing Lesions in Pts with MS
Ann Neurol 43:809-814, Filippi,M.,et al, 1998
Spontaneous Thoracic Spinal Cord Herniation Through an Anterior Dural Defect
AJNR 19:1345-1348, 11851998., Dix,J.E.,et al, 1998
Transdural Spinal Cord Herniation:Imaging and Clinical Spectra
AJNR 19:1337-1344, 11851998., Watters,M.R.,et al, 1998
Acute Vestibular Syndrome
NEJM 339:680-685, Hotson,J.R.&Baloh,R.W., 1998
Guillain-Barre Syndrome
Lancet 352:635-641, Hahn,A.F., 1998
Poliomyelitis-Like Illness Due to Japanese Encephalitis Virus
lancet 351:1094-1097, Solomon,T.,et al, 1998
An Analysis of Extended Survival in Patients with Amyotrophic Lateral Sclerosis Treated with Riluzole
Arch Neurol 55:526-528, Riviere,M.,et al, 1998
Magnetic Resonance Imaging of Muscle in Amyotrophic Lateral Sclerosis
Neurol 51:110-113, Bryan,W.W.,et al, 1998
Extended Use of Glatiramer Acetate (Copaxone) Is Well Tol & Maint Its Clin Effect on MS Relapse Rate & Degree of Disabil
Neurol 50:701-708, Johnson,K.P.,et al, 1998
Intravenous Immunoglobulin Treatment in Multiple Sclerosis, Effect on Relapses
Neurol 50:398-402, Achiron,A.,et al, 1998
Axonal Transection in the Lesions of Multiple Sclerosis
NEJM 338:278-285, 3231998., Trapp,B.D.,et al, 1998
Interferon Treatment for Multiple Sclerosis:Autoimmune Complications May be Lethal
Neurol 50:570-571, Durelli,L.,et al, 1998
Cerebral MR Imaging in Intravascular Lymphomatosis
AJNR 19:427-431, Williams,R.L.,et al, 1998